NEW YORK (GenomeWeb News) – Agilent and SomaLogic said today that they have entered an agreement to expand access to Somalogic's SOMAscan protein biomarker discovery platform by placing it in select academic and contract research centers.

Somalogic has been offering the aptamer-based platform, which uses custom Agilent microarrays, out of its laboratory on a fee-for-service basis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.